發(fā)布時(shí)間：2018-08-26 20:02

【摘要】：目的:探討腫瘤型膝關(guān)節(jié)假體置換術(shù)中應(yīng)用腓腸肌肌瓣進(jìn)行軟組織修復(fù)與重建對(duì)于治療脛骨近端惡性腫瘤的臨床效果。方法:收集2004年-2012年之間于貴州醫(yī)科大學(xué)附院骨科診治的脛骨近端惡性骨腫瘤并行定制腫瘤型膝關(guān)節(jié)假體置換術(shù)的患者62人。按照其手術(shù)方式的不同,分為A、B兩組進(jìn)行回顧性分析。A組為2004-2008年期間收治的30例,術(shù)中未行腓腸肌肌瓣轉(zhuǎn)移覆蓋。B組為2009-2012年期間收治的32例,術(shù)中行腓腸肌肌瓣轉(zhuǎn)移覆蓋。其中骨肉瘤45例,惡性骨巨細(xì)胞瘤9例,惡性纖維組織細(xì)胞瘤6例,軟骨肉瘤2例。Enneking分期IB期4例,IIA期18例,IIB期27例。兩組患者在年齡、性別及病理學(xué)類型方面差異無統(tǒng)計(jì)學(xué)意義。比較A、B兩組在術(shù)后并發(fā)癥發(fā)生率、復(fù)發(fā)率、死亡率、術(shù)后肢體功能評(píng)估等方面的差異。肢體功能評(píng)估包括客觀關(guān)節(jié)活動(dòng)度測量和主觀Enneking評(píng)分兩方面。結(jié)果:全組62例患者中,男性35例(56.5%),女性27例(43.5%)。年齡15-60歲,平均29.24±8.46歲。在術(shù)后并發(fā)癥發(fā)生率方面,術(shù)后嚴(yán)格隨訪24-48個(gè)月,平均36.27±7.41月。術(shù)后發(fā)生并發(fā)癥為11例,B組僅出現(xiàn)2例(6.2%),明顯優(yōu)于A組9例術(shù)后并發(fā)癥(30%)。全組62例患者在隨訪期間4例患者出現(xiàn)了腫瘤復(fù)發(fā),復(fù)發(fā)率為6.5%。9例患者出現(xiàn)遠(yuǎn)處轉(zhuǎn)移,該9例患者均因腫瘤轉(zhuǎn)移導(dǎo)致呼吸循環(huán)衰竭死亡,占14.5%。兩組在復(fù)發(fā)率及死亡率方面無顯著性差異。術(shù)后1年的功能評(píng)分方面,B組主觀Enneking評(píng)分28.44±1.76分,膝關(guān)節(jié)屈曲客觀測量可達(dá)135.63±7.80度,均明顯優(yōu)于A組(主觀Enneking評(píng)分26.70±1.24,膝關(guān)節(jié)屈曲客觀測量106.33±13.6度)。結(jié)論:定制腫瘤型膝關(guān)節(jié)假體置換術(shù)是治療脛骨近端惡性腫瘤的有效方式,其術(shù)中利用腓腸肌肌瓣修復(fù)其周圍軟組織,對(duì)于降低脛骨近端惡性腫瘤手術(shù)并發(fā)癥及有效發(fā)揮人工關(guān)節(jié)功能起著至關(guān)重要的作用,臨床上值得廣泛推廣和應(yīng)用。
[Abstract]:Objective: to investigate the clinical effect of soft tissue reconstruction with gastrocnemius muscle flap in the treatment of proximal tibia malignant tumor. Methods: 62 patients with malignant tumor of proximal tibia treated by orthopaedics department of affiliated hospital of Guizhou Medical University from 2004 to 2012 were enrolled in this study. According to the different operation methods, the patients in group A were divided into two groups. Group A was treated from 2004 to 2008. Group B was treated with gastrocnemius muscle flap in 20092012, while group B was treated with gastrocnemius muscle flap in the period of 2009-2012. The patients in group A were treated with gastrocnemius muscle flap during the period of 2009-2012. Among them, 45 cases of osteosarcoma, 9 cases of malignant giant cell tumor of bone, 6 cases of malignant fibrous histiocytoma, 2 cases of chondrosarcoma. Enneking stage IB 4 cases, 18 cases of IIA stage II B, 27 cases. There was no significant difference in age, sex and pathological type between the two groups. The incidence of postoperative complications, recurrence rate, mortality rate and postoperative limb function evaluation were compared between the two groups. The evaluation of limb function includes objective joint motion measurement and subjective Enneking score. Results: of the 62 patients, 35 (56.5%) were male and 27 (43.5%) were female. The average age was 29.24 鹵8.46 years old. The postoperative complications were followed up for 24-48 months (mean 36.27 鹵7.41 months). There were only 2 cases (6.2%) with postoperative complications in group B, which was significantly better than that in group A (9 cases) (30%). The recurrence rate was 6.5.9 cases with distant metastasis. All the 9 patients died of respiratory and circulatory failure due to tumor metastasis, accounting for 14.5%. There was no significant difference in recurrence rate and mortality between the two groups. One year after operation, the subjective Enneking score of group B was 28.44 鹵1.76, and the objective measurement of knee flexion was 135.63 鹵7.80 degrees, which was significantly better than that of group A (subjective Enneking score 26.70 鹵1.24, knee flexion objective measurement 106.33 鹵13.6 degree). Conclusion: Tumor-type knee prosthesis replacement is an effective method for the treatment of proximal tibial malignant tumor. Gastrocnemius muscle flap is used to repair the surrounding soft tissue during the operation. It plays an important role in reducing the operative complications of proximal tibia malignant tumor and exerting the function of artificial joint effectively. It is worth popularizing and applying widely in clinic.
【學(xué)位授予單位】：貴州醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R738.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 覃澍;董揚(yáng);;腫瘤型膝關(guān)節(jié)假體術(shù)后并發(fā)癥214例分析[J];中國骨與關(guān)節(jié)雜志;2016年02期

2 荊琳;張洪美;韓露;孫鋼;趙鐵軍;顧力軍;張淳;尹天;單鵬程;何名江;;全膝關(guān)節(jié)置換術(shù)治療膝關(guān)節(jié)惡性骨腫瘤[J];中華骨與關(guān)節(jié)外科雜志;2015年05期

3 楊應(yīng)乾;向陽;胡軍;;定制腫瘤型旋轉(zhuǎn)鉸鏈?zhǔn)较リP(guān)節(jié)假體術(shù)后并發(fā)癥發(fā)生相關(guān)因素的探討[J];中國實(shí)用醫(yī)藥;2015年07期

4 鄭勇;秦承東;丁斌;葉爾登;;可旋轉(zhuǎn)穩(wěn)定型假體對(duì)脛骨近端惡性骨腫瘤膝關(guān)節(jié)活動(dòng)度及臨床療效的影響[J];中國腫瘤臨床與康復(fù);2014年10期

5 閆子貴;馬純青;孫曉東;;定制人工假體置換治療骨腫瘤的臨床分析[J];中國醫(yī)藥科學(xué);2014年15期

6 趙思橋;郭征;王tg;范宏斌;付軍;吳智鋼;石磊;;腫瘤型膝關(guān)節(jié)假體置換術(shù)后近期再次手術(shù)的原因分析[J];中國矯形外科雜志;2014年15期

7 陳森;李建平;彭昊;方洪松;周建林;;可旋轉(zhuǎn)穩(wěn)定型假體與單純鉸鏈型假體治療脛骨近端惡性骨腫瘤的臨床療效比較[J];中國矯形外科雜志;2014年02期

8 李展春;陳建偉;李新鋒;董宇啟;王偉力;劉祖德;馬濤;;腫瘤型全膝關(guān)節(jié)假體置換術(shù)治療脛骨近端骨巨細(xì)胞瘤15例分析[J];中國骨與關(guān)節(jié)雜志;2013年11期

9 王臻;;骨腫瘤臨床研究的探討[J];中國骨與關(guān)節(jié)雜志;2013年09期

10 董揚(yáng);白云鵬;張春林;楊慶誠;張智長;朱翔;杜鑫輝;;腓腸肌肌瓣轉(zhuǎn)移重建伸膝裝置在脛骨近端骨腫瘤保肢中的應(yīng)用[J];中國骨與關(guān)節(jié)雜志;2012年06期

相關(guān)會(huì)議論文 前1條

1 王鑫;姚偉濤;蔡啟卿;高嵩濤;張鵬;;復(fù)合筋膜皮瓣修復(fù)骶骨腫瘤術(shù)后局部皮膚壞死[A];第八屆中國腫瘤學(xué)術(shù)大會(huì)暨第十三屆海峽兩岸腫瘤學(xué)術(shù)會(huì)議論文匯編[C];2014年

，

本文編號(hào)：2206010